Overview of the Generation, Validation, and Application of Phosphosite-Specific Antibodies

Methods in Molecular Biology

Volumn 717, Issue , 2011, Pages 3-43

  Brumbaugh, Kathy ^a   Johnson, Wade ^a   Liao, Wen Chieh ^a   Lin, Mong Shang ^a   Houchins, J P ^a   Cooper, Jeff ^a   Stoesz, Steven ^a   Campos Gonzalez, Roberto ^a  

^a R and D Systems Inc   (United States)

Author keywords

Antibody; ELISA; Flow cytometry; Immunocytochemistry; Multiplex; Phosphosite specific; Western blotting

Indexed keywords

ANIMALIA;

PHOSPHOSPECIFIC ANTIBODY; PROTEIN;

ANIMAL; DRUG DEVELOPMENT; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; METABOLISM; METHODOLOGY; PHOSPHORYLATION; PROTEIN PROCESSING; PROTEOMICS; REVIEW; VALIDATION STUDY; WESTERN BLOTTING;

ANIMALS; ANTIBODIES, PHOSPHO-SPECIFIC; BLOTTING, WESTERN; DRUG DISCOVERY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEINS; PROTEOMICS; VALIDATION STUDIES AS TOPIC;

EID: 84855488102     PISSN: 10643745     EISSN: 19406029     Source Type: Book Series    
DOI: 10.1007/978-1-61779-024-9_1     Document Type: Chapter

References (118)

1. Ubersax, J. A., and Ferrell, J. E. Jr. (2007) Mechanisms of specificity in protein phosphorylation. Nat Rev Mol Cell Biol 8, 530–541.
2. Manning, G., Whyte, D. B., Martinez, R., Hunter, T., and Sudarsanam, S. (2002) The protein kinase complement of the human genome. Science 298, 1912–1343.
3. Tarrant, M. K., and Cole, P. A. (2009) The chemical biology of protein phosphorylation. Annu Rev Biochem 78, 797–825.
4. Alonso, A., Sasin, J., Bottini, N., Friedberg, I., Osterman, A., Godzik, A., et al. (2004) Protein phosphatases in the human genome. Cell 117, 699–711.
5. Hunter, T. (2009) Tyrosine phosphorylation: thirty years and counting. Curr Opin Cell Biol 21, 140–146.
6. Boyle, W. J., van der Geer, P., and Hunter T. (1991) Phosphopeptide mapping and phos-phoamino acid analysis by two-dimensional separation on thin-layer cellulose plates. Methods Enzymol 201, 201–240.
7. Ross, A. H., Baltimore, D., and Eisen, H. N. (1981) Phosphotyrosine-containing proteins isolated by affinity chromatography with antibodies to a synthetic hapten. Nature 294, 654–656.
8. Nairn, A. C., Detre, J. A., Casnellie, J. E., and Greengard, P. (1982) Serum antibodies that distinguish between the phospho-and dephospho-forms of a phosphoprotein. Nature 299, 734–736.
9. Glenney, J. R. Jr., Zokas, L., and Kamps, M. P. (1988) Monoclonal antibodies to phosphotyrosine. J Immunol Methods 109, 277–285.
10. Kanakura, Y., Druker, B., Cannistra, S. A., Furukawa, Y., Torimoto, Y., and Griffin, J. D. (1990) Signal transduction of the human granulocyte-macrophage colony-stimulating factor and interleukin-3 receptors involves tyrosine phosphorylation of a common set of cytoplasmic proteins. Blood 76, 706–715.
11. Okamoto, M., Karasik, A., White, M. F., and Kahn, C. F. (1990) Epidermal growth factor stimulated phosphorylation of a 120-kilodal-ton endogenous substrate protein in rat hepatocytes. Biochemistry 29, 9489–9494.
12. Glenney, J. R. Jr. (1989) Tyrosine phosphorylation of a 22-kDa protein is correlated with transformation by Rous sarcoma virus. J Biol Chem 264, 20163–20166.
13. Kanner, S. B., Reynolds, A. B., Vines, R. R., and Parsons, J. T. (1990) Monoclonal anti- bodies to individual tyrosine-phosphorylated protein substrates of oncogene-encoded tyrosine kinases. Proc Natl Acad Sci USA 87, 3328–3332.
14. Towbin, H., Staehelin, T., and Gordon, J. (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76, 4350–4354.
15. Glenney, J. R. Jr. (1992) Tyrosine phosphorylated proteins: mediators of signal transduction from the tyrosine kinases. Biochim Biophys Acta 1134, 113–127.
16. Sefton, B. M. (1982) Phosphorylation and metabolism of the transforming protein of Rous sarcoma virus. J Virol 41, 813–820.
17. Shankaran, H., Ippolito, D. L., Chrisler, W. B., Resat, H., Bollinger, N., Opresko, L. K., et al. (2009) Rapid and sustained nuclear-cytoplasmic ERK oscillations induced by epidermal growth factor. Mol Syst Biol 5, 1–13.
18. Lemeer, S., and Heck, A. J. (2009) The phosphoproteomics data explosion. Curr Opin Chem Biol 13, 414–420.
19. Kehoe, J. W., Velappan, N., Walbolt, M., Rasmussen, J., King, D., Lou, J., et al. (2006) Using phage display to select antibodies recognizing post-translational modifications independently of sequence context. Mol Cell Proteomics 5, 2350–2363.
20. Harlow, E., and Lane, D. (1988) Antibodies: a laboratory manual. New York: Cold Spring Harbor Laboratory Press.
21. Weng, Q-P., Kozlowski, M., Belham, C., Zhang, A., Comb, M. J., et al. (1995) Regulation of the p70 S6 kinase by phosphorylation in vivo. J Biol Chem 273, 16621–16629.
22. Yung, Y., Dolginov, Y., Zao, Z., Rubinfeld, H., Michael, D., Hanoch, T., et al. (1997) Detection of ERK activation by a novel monoclonal antibody. FEBS Lett 408, 292–296.
23. Campos-Gonzalez, R., and Glenney, J. R. Jr. (1991) Immunodetection of the ligand-activated receptor for epidermal growth factor. Growth Factors 4, 305–316.
24. Sternberger, L. A., and Sternberger, N. H. (1983) Monoclonal antibodies distinguish phosphorylated and nonphosphorylated forms of neurofilaments in situ. Proc Natl Acad Sci USA 80, 6126–6130.
25. Heffetz, D., Fridkin, M., and Zick, Y. (1991) Generation and use of antibodies to phosphothreonine. Methods Enzymol 201, 44–52.
26. Wang, J. Y. (1991) Generation and use of anti-phosphotyrosine antibodies raised against bacterially expressed abl protein. Methods Enzymol 201, 53–65.
27. Briand, J. P., Muller, S., and Van Regenmortel, M. H. V. (1985) Synthetic peptides as antigens: pitfalls of conjugation methods. J Immunol Methods 78, 59–69.
28. Epstein, R. J., Druker, B. J., Roberts, T. M., and Stiles, C. D. (1992) Synthetic phosphopeptide immunogens yield activation-specific antibodies to the c-erbB-2 receptor. Proc Natl Acad Sci USA 89, 10435–10439.
29. Edbauer, D., Cheng, D., Batterton, M. N., Wang, C.-F., Duong, D. M., et al. (2009) Identification and characterization of neuronal mitogen-activated protein kinase substrates using a specific phosphomotif antibody. Mol Cell Proteomics 8, 681–695.
30. Shi, Y., Dodson, G. E., Mukhopadhyay, P. S., Shanware, N. P., Trinh, A. T., and Tibbetts, R. S. (2007) Identification of carboxyl-terminal MCM3 phosphorylation sites using polyreactive phosphospecific antibodies. J Biol Chem 282, 9236–9243.
31. Tam, J. P., and Zavala, F. (1989) Multiple antigen peptide: a novel approach to increase detection sensitivity of synthetic peptides in solid-phase immunoassays. J Immunol Methods 124, 53–61.
32. Spieker-Polet, H., Sethupathi, P., Yam, P. C., and Knight, K. L. (1995) Rabbit monoclonal antibodies: generating a fusion partner to produce rabbit-rabbit hybridomas. Proc Natl Acad Sci USA 92, 9348–9352.
33. 32a. Babcook, J. S., Leslie, K. B., Olsen, O. A., Salmon, R. A., and Schrader, J. H. (1996) Proc Natl Acad Sci USA 93, 7843–7848.
34. Ruff-Jamison, S., Campos-Gonzalez, R., and Glenney, J. R. Jr. (1991) Heavy and light variable region sequences and antibody properties of anti-phosphotyrosine antibodies reveal both common and distinct features. J Biol Chem 266, 6607–6613.
35. Ruff-Jamison, S., and Glenney, J. R. Jr. (1993) Requirements for both H and L chain V regions, VH and VK joining amino acids, and the unique H chain D region for the high affinity binding of an anti-phosphotyrosine antibody. J Immunol 150, 3389–3396.
36. Ruff-Jamison, S., and Glenner, J. R. Jr. (1993) Molecular modeling and site-directed mutagenesis of an anti-phosphotyrosine antibody predicts the combining site and allows the detection of higher affinity interactions. Protein Eng 6, 661–668.
37. Tuckey, C. D., and Noren, C. J. (2002) Selection for mutants improving expression of an anti-MAP kinase monolconal antibody by filamentous phage display. J Immunol Methods 270, 247–257.
38. Campos-Gonzalez, R., and Glenney, J. R. Jr. (1991) Temperature-dependent tyrosine phosphorylation of microtubule-associated protein kinase in epidermal growth factor-stimulated human fibroblasts. Cell Regul 2, 663–673.
39. Vaughan, M. H., Xia, X., Wang, X., Chronopoulou, E., Gao, G. J., Campos-Gonzalez, R., et al. (2007) Generation and characterization of a novel phospho-specific monoclonal antibody to p120-catenin serine 879 Hybridoma 26, 407–415.
40. Borrebaeck, C. A. K., Malmborg, A. C., Furebring, C., Michaelsson, A., Ward, S., Danielsoon, L., et al. (1992) Kinetic analysis of recombinant antibody-antigen interactions: relation between structural domains and antigen binding. Nat Biotechnol 10, 697–698.
41. Michalewski, M. P., Kaczmarski, W., Golabek, A., Kida, E., Kaczmarski, A., and Wisniewski, K. E. (2002) Immunoblotting with anti-phosphoamino acid antibodies: importance of the blocking solution. Anal Biochem 276, 254–257.
42. Song, K. S., Tang, Z., and Lisanti, M. P. (1997) Mutational analysis of the proteper-ties of caveolin-1. A novel role for the C-terminal domain in mediating homo-typic caveolin-caveolin interactions. J Biol Chem 271, 4398–4403.
43. Heinrich, M. C., Griffith, D. J., Druker, B. J., Wait, C. L., Ott, K. A., and Zigler, A. J. (2000) Inhibition of c-kit receptor tyrosine kinase kinase activity by STI571, a selective tyrosine kinase inhibitor. Blood 96, 925–932.
44. Nelson, E. A., Walker, S. R., Kepich, A., Gashin, L. B., Hideshima, T., Ikeda, H., et al. (2008) Nifuroxazide inhibits survival of multiple myeloma cells by directly inhibiting STAT3. Blood 112, 5095–5102.
45. Hardie, D. G., Haystead, T. A. J., and Sim, A. T. R. (2001) Use of okadaic acid to inhibit protein phosphatases in intact cells. Methods Enzymol 201, 531–538.
46. Gordon, J. A. (2001) Use of vanadate as protein-phosphotyrosine phosphatase inhibitor. Methods Enzymol 201, 581–586.
47. Evans, G. A., Garcia, G. G., Erwin, R., Howard, O. M., and Farrar, W. L. (1994) Pervanadate stimulates the effects of interleukin-2 (IL-2) in human T cells and provides evidence for the activation of two distinct tyrosine kinase pathways by IL-2. J Biol Chem 269, 23407–23412.
48. Ruff, S. J., Chen, K., and Cohen, S. (1997) Peroxovanadate induces tyrosine phosphorylation of multiple signaling proteins in mouse liver and kidney. J Biol Chem 272, 1263–1267.
49. Yang, T. T., Yu, R. Y., Agadir, A., Gao, G. J., Campos-Gonzalez, R., Tournier, C., and Chow, C. W. (2008) Integration of protein kinases mTOR and extracellular signal-regulated kinase 5 in regulating nucleocyto-plasmic localization of NFATc4. Mol Cell Biol 28, 3489–3501.
50. Espina, V., Edmiston, K. H., Heiby, M., Pierobon, M., Sciro, M., Merritt, B., Banks, S., Deng, J., VanMeter, A. J., Geho, D. H., Pastore, L., Sennesh, J., Petricoin, E. F., and Liotta, L. A. (2008) A portrait of tissue phosphoprotein stability in the clinical tissue procurement process. Mol Cell Proteomics 7, 1998–2018.
51. Gilbert, C., Rollet-Labelle, E., Con, A. C., and Naccache, P. H. (2002) Immunoblotting and sequential lysis protocols for the analysis of tyrosine phosphorylation-dependent signaling. J Immunol Methods 271, 185–201.
52. Skolnik, E. Y., Lee, C. H., Batzer, A., Vicentini, L. M., Zhou, M., Daly, R., et al. (1993) The SH2/SH3 domain-containing protein GRB2 interacts with tyrosine-phosphorylated IRS1 and Sch: implications for insulin control of ras signaling. EMBO J 12, 1929–1936.
53. Barbareschi, M., Girlando, S., Mauri, F. M., Eccher, C., Mauri, F. A., Togni, R., et al. (1994) Quantitative growth fraction evaluation with MIB1 and Ki67 antibodies in breast carcinomas. Am J Clin Pathol 102, 171–175.
54. Mandell, J. W. (2003) Phosphorylation state-specific antibodies. Applications in investigative and diagnostic pathology. Am J Pathol 163, 1687–1698.
55. Bordeaux, J., Welsh, A. W., Agarwal, S., Killiam, E., Baquero, M. T., Hanna, J. A., Anagnostou, V. K., and Rimm, D. L. (2010) Antibody validation. Biotechniques 48, 197–209.
56. Mandell, J. W. (2008) Immunohistochemical assesment of protein phosphorylation state: the dream and the reality. Histochem Cell Biol 130, 465–471.
57. Kalyuzhny, A. E. (2009) The dark side of the immunohistochemical moon: industry. J Histochem Cytochem 57, 1099–1101.
58. Krutzik, P. O., Irish, J. M., Nolan, G. P., and Perez, O. D. (2004) Analysis of protein phosphorylation and cellular signaling events by flow cytometry: techniques and clinical applications. Clin Immunol 110, 206–221.
59. Perez, O. D., Mitchell, D., Campos, R., Gao, G-J., Li, L., and Nolan, G. P. (2005) Multiparameter analysis of intracellular phosphoepitopes in immunophenotyped cell populations by flow cytometry. Curr Protoc Cytom 6, 1–22.
60. Chow, S., Patel, H., Hedley, D. W. (2001) Measurement of MAP kinase activation by flow cytometry using phospho-specific antibodies to MEK and ERK: potential for pharmacodynamic monitoring of signal transduction inhibitors. Cytometry 46, 72–78.
61. Lombardi Givan, A. (2001) Flow cytometry. First principles. 2nd edition. New York: Wiley-Liss.
62. Smith, C. L., Debouk, C., Rosenberg, M., and Culp, J. S. (1988) Phosphorylation of ferine residue 89 of human adenovirus E1A proteins is responsible for their characteristic electrophoretic mobility shits, and its mutation affects biological fuction. J Virol 63, 1569–1577.
63. Wegener, A. D., and Jones, L. R. (1984) Phosphorylation-induced mobility shift in phospholamban in sodium dodecyl sulfate-polyacrylamide gels. Evidence for a protein structure consisting of multiple identical phosphorylatable subunits. J Biol Chem 259, 1834–1841.
64. Jorgensen, C. S., Jagd, M., Sorensen, B. K., McGuire, J., Barkholt, V., Hojrup, P., et al. (2004) Efficacy and compatibility with mass spectrometry of methods for elution of proteins from sodium dodecyl sulfate-polyacrylamide gels and polyvinyldifluoride membranes. Anal Biochem 330, 87–97.
65. Forrer, P., Tamaskovic, R., and Jaussi, R. (1998) Enzyme-linked immunosorbent assay for measurement of JNK, ERK and p38 kinase activities. Biol Chem 379, 1101–1111.
66. Suzuki, S., Tamai, K., and Yoshida, S. (2002) Enzyme-linked immunosorbent assay for distinct cyclin-dependent kinase activities using phosphorylation-site-specific anti pRB monoclonal antibodies. Anal Biochem 301, 65–74.
67. Offterdinger, M., and Bastiaens, P. I. (2008) Prolonged EGFR signaling by ERBB2-mediated sequestration at the plasma membrane. Traffic 9, 147–155.
68. Loos, T., Mortier, A., Gouwy, M., Ronsee, I., Put, W., Lenaerts, J-P., et al. (2008) Citrullination of CXCL10 and CXCL11 by peptidylarginine diminase: a naturally occurring posttranslational modification of chemockines and new dimension of immu-noregulation. Blood 112, 2648–2656.
69. Ramos, J. W. (2008) The regulation of extracellular signal-regulated kinase (ERK) in mammalian cells. Int J Biochem Cell Biol 40, 2707–2719.
70. Gonzalez, E., and McGraw, T. E. (2009) The Akt kinases: isoform specificity in metabolism and cancer. Cell Cycle 8, 2502–2508.
71. Ribeiro-Oliveira, A. Jr., Franchi, G., Kola, B., Dalino, P., Pinheiro, S. V., Salahuddin, N., et al. (2008) Protein western array analysis in human pituitary tumors: insights and limitations. Endocr Relat Cancer 15, 1099–1114.
72. Pelech, S., Sutter, C., and Zhang, H. (2003) Kinetworks protein kinase multiblot analysis. Methods Mol Biol 218, 99–111.
73. Ciaccio, M. F., Wagner, J. P., Chuu, C.-P., Lauffenburger, D. A., and Jones, R. B. (2010) Systems analysis of EGF receptor signaling dynamics with microwestern arrays. Nat Methods 7, 148–155.
74. Rikova, K., Guo, A., Zeng, Q., Possemato, A., Yu, J., Haack, H., et al. (2007) Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer. Cell 131, 1190–1203.
75. Mayya, V., Lundgren, D. H., Hwang, S.-I., Rezaul, K., Wu, L., Eng, J. K., Rodionov, V., and Han, D. K. (2009) Quantitative phospho-proteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-pro-tein interactions. Sci Signal 2, ra46 1–ra46 16.
76. Fan, A., Deb-Basu, D., Orban, M. W., Gotlib, J. R., Natkunam, Y., O’Neill, R., et al. (2009) Nanofluidic proteomic assay for serial analysis of oncoprotein activation in clinical samples. Nat Med 15, 566–571.
77. Hughes, T. R., and Shoemaker, D. D. (2001) DNA microarrays for expression profiling. Curr Opin Chem Biol 5, 21–25.
78. Andersson, O., Kozlowski, M., Garachtchenko, T., Nikoloff, C., Lew, N., Litman, D. J., et al. (2005) Determination of relative protein abundance by internally normalized ratio algorithm with antibody arrays. J Proteome Res 4, 758–767.
79. Pelech, S., Jelinkova, L., Susor, A., Zhang, H., Shi, X., Pavlok, A., et al. (2008) Antibody microarray analyses of signal transduction protein expression and phosphorylation during porcine oocyte maturation. J Proteome Res 7, 2860–2871.
80. MacBeath, G. (2002) Protein microarrays and proteomics. Nat Genet 32, 526–532.
81. Russo, G., Zegar, C., and Giordano, A. (2003) Advantages and limitations of microarray technology in human cancer. Oncogene 22, 6497–6507.
82. Nielsen, U. B., Cardone, M. H., Sinskey, A. J., MacBeath, G., and Sorger, P. K. (2003) Profiling receptor kinase activation by using Ab microarrays. Proc Natl Acad Sci USA 100, 9330–9335.
83. Liu, X., Kim, P., Kirkland, R., Magonova, K., Liu, L., Zhang, I., et al. (2009) Prevalence of activated & total p95HER2 and other receptor tyrosine kinases in breast cancer. AACR San Antonio Breast Cancer Symposium Abstract #3053.
84. Paweletz, C. P., Charboneau, L., Bichsel, V. E., Simone, N. L., Chen, T., Gillespie, J. W., et al. (2001) Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front. Oncogene 20, 1981–1989.
85. Espina, V., Woodhouse, E. C., Wulfkuhle, J., Asmussen, H. D., Petricoin, E. F., and Liotta, L. A., (2004) Protein microarray detection strategies: focus on direct detection technologies. J Immunol Methods 290, 121–133.
86. Spurrier, B., Ramalingam, S., and Nishizuka, S. (2008) Reverse-phase protein lysate microarrays for cell signaling analysis. Nat Protoc 3, 1796–1808.
87. Chan, S. M., Ermann, J., Su, L., Fathman, C. G., and Utz, P. J. (2004) Protein microarrays for multiplex analysis of signal transduction pathways. Nat Med 10, 1390–1396.
88. Natarajan Mendes, K., Nicorici, D., Cogdell, D., Tabus, I., Ylf-Harga, O., Guerra, R., et al. (2007) Analysis of signaling pathways in 90 cancer cell lines by protein lysate array. J Proteome Res 6, 2753–2767.
89. Schweitzer, B., Roberts, S., Grimwade, B., Shao, W., Wang, M., Fu, Q., et al. (2002) Multiplex protein profiling on microarrays by rolling-circle amplification. Nat Biotechnol 20, 359–365.
90. Dahut, W. L., Scripture, C., Posadas, E., Jain, L., Gulley, J. L., Arlen, P. M., et al. (2008) A phase II clinical trial of sorafenib in androgen-independent prostate cancer. Clin Cancer Res 14, 209–214.
91. Tan, C. S. H., Bodenmiller, B., Pascualescu, A., Jovanovic, M., Hengartner, M. O., Jorgensen, C., et al. (2009) Comparative analysis reveals conserved protein phosphorylation networks implicated in multiple diseases. Sci Signal 2, ra39 1–ra39 13.
92. Drucker, B. J. (2009) Perspectives on the development of imatinib and the future of cancer research. Nat Med 10, 1149–1152.
93. Jilani, I., Kanttarjian, H., Gorre, M., Cortes, J., Ottmann, O., Bhalla, K., et al. (2008) Phosphorylation levels of BCR-ABL, CrkL, AKT, and STAT5 in imatinib-resistant chronic myeloid leukemia cells implicate alternative pathway usage as a survival strategy. Leuk Res 32, 643–649.
94. Irish, J. M., Kotecha, N., and Nolan, G. P. (2006) Mapping normal and cancer cell signaling networks: towards single-cell proteomics. Nat Rev Cancer 6, 146–155.
95. Juan, G., Gruenwald, S., and Darzynkiewicz, Z. (1998) Phosphorylation of retinoblas-toma susceptibility gene protein assayed in individual lymphocytes during their mito-genic stimulation. Exp Cell Res 239, 104–110.
96. Juan, G., Traganos, F., and Darzynkiewicz, Z. (1999) Histone H3 phosphorylation in human monocytes and during HL-60 cell differentiation. Exp Cell Res 246, 212–220.
97. Zell, T., Khoruts, A., Ingulli, E., Bonnevier, J. L., Mueller, D. L., and Jenkins, M. K. (2001) Single-cell analysis of signal transduction in CD4 T cells stimulated by antigen in vivo. Proc Natl Acad Sci USA 98, 10805–10810.
98. Krutzik, P. O., Hale, M. B., and Nolan, G. P. (2005) Characterization of the murine immunological signaling network with phosphospecific flow cytometry. J Immunol 175, 2366–2373.
99. Lu, X. P., Alpdogan, O., Lin, J., Balderas, R., Campos-Gonzalez, R., Wang, X., et al. (2008) STAT-3 and ERK1/2 phosphorylation are critical for T-cell activation and graft-versus-host disease. Blood 112, 5254–5258.
100. Perez, O. D., and Nolan, G. P. (2002) Simultaneous measurement of multiple active kinase states using polychromatic flow cytometry. Nat Biotechnol 20, 155–162.
101. Shachaf, C. M., Elchuri, S. V., Koh, A. L., Zhu, J., Nguyen, L. N., Mitchell, D. J., et al. (2009) A novel method for detection of phosphorylation in single cells by surface enhanced raman scattering (SERS) using composite organic-inorganic nanoparticles. PLoS One 4, e5206 1–e5206 12
102. Irish, J. M., Hovland, R., Krutzik, P. O., Perez, O. D., Bruserud, O., Gjertsen, B. T., and Nolan, G.P. (2004) Single cell profiling of potentiated phospho-protein networks in cancer cells. Cell 118, 217–228.
103. Hale, M. B., Krutzik, P. O., Samra, S. S., Crane, J. M., and Nolan, G. P. (2009) Stage dependent aberrant regulation of cytokine-STAT signaling in murine systemic lupus erythematosus. PLoS One 4, e6756 1–e6756 10.
104. Krutzik, P. O., and Nolan, G. P. (2006) Fluorescent cell barcoding in flow cytometry allows high-throughput drug screening and signaling profiling. Nat Methods 3, 361–368.
105. Pritchard, J. R., Cosgrove, B. D., Hemann, M. T., Griffith, L. G., Wands, J. R., and Lauffenburger, D. A. (2009) Three-kinase inhibitor combination recreates multipath-way effects of a geldanamycin analogue on hepatocellular carcinoma cell death. Mol Cancer Ther 8, 2183–2192.
106. Morgan, E., Varro, R., Sepulveda, H., Ember, J. A., Apgar, J., Wilson, J., et al. (2004) Cytometric bead array: a multiplexed assay platform with applications in various areas of biology. Clin Immunol 110, 252–266.
107. Chen, L., Huynh, L., Apgar, J., Tang, L., Rassenti, L., Weiss, A., and Kipps, T. J. (2008) ZA-70 enhances IgM signaling independent of its kinase activity in chronic lym-phocytic leukemia. Blood 111, 2685–2692.
108. Massarelli, E., Liu, D. D., Lee, J. J., El-Naggar, A. K., Lo Muzio, L., Staibano, S., et al. (2005) Akt activation correlates with adverse outcome in tongue cancer. Cancer 104, 2430–2436.
109. Smitz, K. J., Otterbach, F., Callies, R., Levkau, B., Holscher, M., Hoffmann, O., et al. (2004) Prognostic relevance of activated Akt kinase in node-negative breast cancer: a clinicopathological study of 99 cases. Mol Pathol 17, 15–21.
110. Okamoto, I., Kenyon, L. C., Emlet, D. R., Mori, T., Sasaki, J., Hirosako, S., et al. (2003) Expression of activated EGFRvIII in small cell lung cancer. Cancer Sci 94, 50–56.
111. D’Andrea, M. R., Mel, J. M., Tuman, R. W., Galemmo, R. A., and Johnson, D. L. (2005) Validation of in vivo pharmacodynamic activity of a novel PDGF receptor tyrosine kinase inhibitor using immunohistochemistry and quantitative image analysis. Mol Cancer Ther 4, 1198–1204.
112. Kong, A., Leboucher, P., Leek, R., Calleja, V., Winter, S., Harris, A., et al. (2006) Prognostic value of an activation state marker for epidermal growth factor receptor in tissue microarrays of head and neck cancer. Cancer Res 66, 2834–2843.
113. VanMeter, A. J., Rodriguez, A. S., Bowman, E. D., Jen, J., Harris, C. C., Deng, J., et al. (2008) Laser capture microdissection and protein microarray analysis of human non-small cell lung cancer. Mol Cell Proteomics 7, 1902–1924.
114. Nagai, Y., Miyasaki, M., Akoi, R., Zama, T., Inouye, S., Hirose, K., et al. (2000) A fluorescent indicator for visualizing cAMP-induced phosphorylation in vivo. Nat Biotechnol 18, 313–316.
115. Ng, T., Squire, A., Hansra, G., Bornancin, F., Prevostel, C., Hanby, A., et al. (1999) Imaging protein kinase Calpha activation in cells. Science 283, 2085–2089.
116. Tomida, T., Takekawa, M., O’Grady, P., and Saito, H. (2009) Stimulus-specific distinctions in spatial and temporal dynamics of stress-activated protein kinase kinase kinases revealed by a fluorescence resonance energy transfer biosensor. Mol Cell Biol 29, 6117–6127.
117. Ting, A. Y., Kain, K. H., Klemke, R. L., and Tsien, R. Y. (2001) Genetically encoded fluorescent reporters of protein tyrosine kinase activities in living cells. Proc Natl Acad Sci USA 98, 15003–15008.
118. Kelleher, M. T., Fruhwirth, G., Patel, G., Ofo, E., Festy, F., Barber, P. R., et al. (2009) The potential of optical proteomic technologies to individualize prognosis and guide rational treatment for cancer patients. Target Oncol 4, 235–252.